Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Actual shortage | 2024-03-07 | 2024-03-28 | 221537 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1694 |
LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1711 |
ONDANSETRON INJECTION | 2MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1746 |
ONDANSETRON INJECTION | 2MG | SOLUTION | Actual shortage | 2017-03-13 | 2017-10-05 | 1754 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42591 |
TEVA-LOPERAMIDE | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42594 |
TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42632 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43135 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2018-06-22 | 2018-10-11 | 52823 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61346 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2018-12-04 | 2019-08-06 | 68608 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86945 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86948 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92180 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95373 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95378 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-11-01 | 95381 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |